TrialAntimicrobial agents and chemotherapy2021

Pharmacokinetics and Safety of XAV-19, a Swine Glyco-humanized Polyclonal Anti-SARS-CoV-2 Antibody, for COVID-19-Related Moderate Pneumonia: a Randomized, Double-Blind, Placebo-Controlled, Phase IIa Study.

Benjamin Gaborit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.